Taking Legal Avenues For Studies Of Controlled Substances

Today on Hempresent our host Vivian McPeak is joined by Brad Burge about the success of MAPS’ Legalizing Psychedelic Therapy campaign raising funds for MAPS research. Burge speaks about MAPS’ current psychedelic and marijuana research program, highlights the various accomplishments of MAPS’ crowdfunding efforts, and details the results and progress of MAPS’ clinical research into MDMA-assisted psychotherapy for PTSD. MAPS is a non-profit, private donation funded organization.

They discuss how MAPS takes legal avenues for studies of controlled substances. They envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits. They currently have an Indiegogo campaign for legalizing psychedelic medicine.

MAPS is currently raising funds for Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD and people can learn more at www.maps.org.